Top Markets
#1 DeFiChain DeFiChain +2,516.54%
#2 Akedo Akedo +207.46%
#3 ONFA ONFA +54.25%
#4 Metaplex Metaplex +23.40%
#5 Osaka Protocol Osaka Protocol +21.54%
#6 Wrapped Krown Wrapped Krown +20.00%
#7 Talus Network Talus Network +19.98%
#8 DODO DODO +17.78%
#9 Black Phoenix Black Phoenix +15.09%
#10 Magma Finance Magma Finance +14.74%
Coin of the day
DeFiChain DeFiChain
Настройки
Язык
Pусский
Валюта
USD
Тема
Valbiotis SA Valbiotis SA

Valbiotis SA

ALVAL
Ранг среди акций #16315
Valbiotis SA engages in the research and development of health nutrition... Valbiotis SA engages in the research and development of health nutrition products to prevent and combat metabolic and cardiovascular diseases. The company develops TOTUM-63 that is in Phase II/III clinical trials for the treatment of type 2 diabetes; TOTUM-070, which is in Phase II clinical trials to treat hypercholesterolemia; and TOTUM-854 that is in Phase II/III clinical trials for arterial hypertension. It also develops TOTUM-448 for the treatment of patient with non-alcoholic fatty liver disease. It has a strategic partnership with Nestlé Health Science. Valbiotis SA was incorporated in 2014 and is headquartered in Périgny, France.
Цена акции
$0.94180721
Рыночная капитализация
$22.26M
Изменение (1 день)
0.38%
Изменение (1 год)
-14.35%
Страна
FR
Торговля Valbiotis SA (ALVAL)

Категория

Healthcare
Коэффициент P/B для Valbiotis SA (ALVAL)
Коэффициент P/B на July 2026 TTM: 2.69
Согласно последним финансовым отчетам и цене акций Valbiotis SA, текущий коэффициент P/B (TTM) составляет 2.69. В конце 2023 он составлял 3.18.
История P/B для Valbiotis SA с 2015 по 2026
Коэффициент P/B в конце каждого года
Год P/B Изменить
2026 (TTM) 2.69 16.05%
2024 2.32 -27.16%
2023 3.18 16.23%
2022 2.74 -37.95%
2021 4.41 -30.21%
2020 6.32 392.65%
2019 1.28 -22.00%
2018 1.64 -0.78%
2017 1.66 -98.28%
2016 96.41 6,215.43%
2015 1.53 0.00%
Коэффициент P/B для аналогичных компаний или конкурентов
Компания P/B Разница P/B Страна
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
 6.9942 159.78%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.251 132.17%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 2.1715 -19.35%
US
UCB SA UCB SA
UCB SA
UCB.BR
 4.065 50.98%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
 7.3009 171.17%
NL